Skip to main content
padlock icon - secure page this page is secure

Low Expression of Circadian Rhythm Protein PER1 and CRY1 in Gastric Cancer

Buy Article:

$106.51 + tax (Refund Policy)

Period (Per) and Cryptochrome (Cry) are important clock-controlled genes, disturbing their transcription will induce over-activity of carcinogenesis and increase the incidence and prognosis of various cancers. However, the expressions of PER1 and CRY1 in gastric cancer (GC) are still few understood. In this study, the expressions of PER1 and CRY1 in cancerous and noncancerous tissues from GC patients were detected by IHC and the IHC sections were scored. The IHC results showed that the expressions of PER1 and CRY1 were reduced in cancerous tissues compared with noncancerous tissues. Moreover, their expressions were both significantly associated with the location of tumor, histological differentiation, lymph node metastasis, distant metastasis, depth of invasion and TNM stage. Meanwhile, down-regulated PER1 and CRY1 expressions were dramatically observed in cancers with deep invasion, good differentiation and more advanced stages. Furthermore, the expression of PER1 was positively correlated with the expression of CRY1 (r =0.828, P <0.01). Kaplan-Meier analysis showed patients with higher PER1 and CRY1 expressions had a longer survival time than those with lower expression. Univariate and multivariate analysis demonstrated that cell differentiation levels and TNM stage were independent prognostic factors. PER1 and CRY1 may play important roles in the development, invasion and prognosis of GC.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics

Keywords: CIRCADIAN RHYTHM; CRY1; GASTRIC CANCER; IMMUNOHISTOCHEMISTRY; PER1

Document Type: Short Communication

Publication date: July 1, 2017

More about this publication?
  • Nanoscience and Nanotechnology Letters (NNL) is a multidisciplinary peer-reviewed journal consolidating nanoscale research activities in all disciplines of science, engineering and medicine into a single and unique reference source. NNL provides the means for scientists, engineers, medical experts and technocrats to publish original short research articles as communications/letters of important new scientific and technological findings, encompassing the fundamental and applied research in all disciplines of the physical sciences, engineering and medicine.
  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more